Monoclonal gammopathy in systemic lupus erythematosus

Lupus

Volumn 16, Issue 6, 2007, Pages 426-429

  Ali, Y M ^a   Urowitz, M B ^a   Ibanez D ^a   Gladman, Dafna ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Monoclonal gammopathy; Prognosis; SLE

Indexed keywords

ANTIMALARIAL AGENT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; STEROID;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DRUG DOSE REGIMEN; ELECTROPHORESIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BLOOD SEDIMENTATION; DATABASES, FACTUAL; FEMALE; GAMMA-GLOBULINS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MONOCLONAL GAMMOPATHIES, BENIGN; NEOPLASMS; PREVALENCE;

EID: 34547217499     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307079045     Document Type: Article

References (24)

1. Waldenstrom J. Studies in conditions associated with disturbed gammaglobulin formation. Harvey Lectures 1961; 56: 211-213.
2. Kyle RA. Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Am J Med 1978; 64: 814-826.
3. The International Myeloma Working Group. Criteria for file classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the international myeloma working group. Br J Haematol 2003; 121: 749-757.
4. Crawford J, Eye MKm, Cohen HJ. Evaluation of monoclonal gammopathies in the "well" elderly. Am J Med 1987; 82: 39-45.
5. Kyle RA. Monoclonal gammopathy of undertermined significance (MGUS): a review. Clin Haematol 1982; 11: 123-150.
6. Hallen J. Discrete gammaglobulin (M) components in serum: clinical study of 150 subjects without myelomatosis. Acta Med Scand 1966; 5(Suppl 462): 1-127.
7. Isobew T, Osserman EF. Pathologic conditions associated with plasma cell dyscrasias: a study of 806 cases. Ann NY Acad Sci 1971; 90: 507-518.
8. Bernatsky S, Ramsey-Goldman R, Boivin JF et al. An international cohort study of cancer in systemic lupus erythematosus (SLE). Arthritis Rheum 2005; 52: 1481-1490.
9. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
10. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29: 288-291.
11. Gladman DD, Goldsmith C, Urowitz M et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 2000; 27: 373-376.
12. Alarcon-Segovia D, Fishbein E: Serum immunoglobulins in systemic lupus erythematosus. Clin Sci 1972; 43: 121-131.
13. Fauci AS, Moutsopoulos HM. Polyclonally triggers B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus. Arthritis Rheum 1981; 24: 577-584.
14. Goldstein G, Warner NL, HoLmes MC. Plasma-cell tumor induction in (NZB X BALB/c) FI hybrid mice. J Natl Cancer Inst 1966; 37: 135-143.
15. Canoso JJ, Cohen AS. Malignancy in a series of 70 patients with systemic lupus erythematosus. Arthritis Rheum 1974; 17: 383-390.
16. Jordan E, Burnstein SL, Calabro JJ, Henderson ES. Multiple myeloma complicating the course of seronegative systemic lupus erythematosus. Arthritis Rheum 1978; 21: 260-265.
17. Pehamberger H, Diem E, Konrad K. Systemic lupus erythematosus with multiple myeloma. Acta Derm Venereol (Stockh) 1978; 58: 527-530.
18. Braunstein EM, Weissman BN, Sosman JL, Schur PH. Radiologic findings in late-onset systemic lupus erythematosus. Am J Roentgeno 1983; 140: 587-589.
19. Powell FC, Greipp PR, Su WPD. Discoid lupus erythematosus and monoclonal gammopathy. Brit J Dermatol 1983; 109: 355-360.
20. Butler RC, Thomas SM, Thompson JM, Keat ACS. Anaplastic myeloma in systemic lupus erythematosus. Ann Rheum Dis 1984; 43: 653-655.
21. Solary E, Caillot D, Guy H, Olsson ND, Tanter Y, Chalopin JM. Systemic lupus erythematosus occurring in a patient with multiple myeloma (letter). Arthritis Rheum 1986; 29: 933-934.
22. Sendagorta E, Matarredona J, Brieva JA, Rodriguez ML, Ledo A. Systemic lupus erythematosus in association with smoldering multiple myeloma (letter). J Am Acad Dermatol 1987; 16: 135-136.
23. Huston DR, McAdam KPWJ, Balow JE, Bass R, Deheliss RA. Amyloidosis in systemic lupus erylhematosus. Am J Med 1981; 70: 320-323.
24. Bulter WT, Rossen RD. Effects of corticosteroid on immunity. Clin Invest 1973; 52: 2629-2640.